A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty

NACompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

October 19, 2018

Primary Completion Date

April 15, 2022

Study Completion Date

May 22, 2022

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DEVICE

Direct Selective Trabeculoplasty

Laser surgery by automated direct automated SLT device to lower intraocular pressure

DEVICE

Selective Trabeculoplasty

Laser surgery by standard SLT device to lower intraocular pressure

Trial Locations (8)

Unknown

Soroka Medical Center, Beersheba

Rambam Medical Center, Haifa

Wolfson Medical Center, Holon

Shaare Zedek Medical Center, Jerusalem

Rabin Medical Center, Petah Tikva

Universita degli Studi di Genova, Genova

Queens University Belfast, Belfast

EC1V 2PD

Moorfields Eye Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

Universita degli Studi di Genova

OTHER

collaborator

Queen's University, Belfast

OTHER

collaborator

Moorfields Eye Hospital NHS Foundation Trust

OTHER

lead

BelkinVision

INDUSTRY

NCT03750201 - A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty | Biotech Hunter | Biotech Hunter